FM 2023 Product Inquiry - ThermaSolutions – Hyperthermic Intraperitoneal Chemotherapy

Skip to content

Request Info

Contact

Our Story
Products
Distributors
Training & Support
Job Openings
News

This content is password protected. To view it please enter your password below:

Password:

Our Certifications

21 CFR Quality Systems Regulation Part 820 of the Federal Food and Drug Administration (FDA).
EN/ISO 13485:2016 • MDD 93/42/EEC

U.S. Headquarters

1889 Buerkle Road
White Bear Lake, MN 55110
Tel. +1 651 209 3900
Fax +1 651 209 3903

Toll Free: +1 877 952 6100

General Questions:

International Office

Takkebijsters 41
4817 BL Breda
The Netherlands
Tel. +31 76 579 1144

Direct:

Products

ThermoChemTM HT-2000
ThermoChemTM HT-2500
Disposable HIPEC Procedure Kits
Find Us
Distributors Only

Training & Support

IPH Kit: Training Videos
TSP Kit: Training Videos
HIPEC Program Support
HIPEC Resources
Support for HT-1000

*FDA Disclaimer: ThermoChem™ HT-2000 (or HT-1000) has not been cleared for use to treat any specific disease state or condition. Chemotherapy drugs used during the Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedure are currently approved for the treatment of certain cancers. A number of clinical studies and literature exist regarding the use of HIPEC in the peritoneum using intraperitoneal heating devices, such as the ThermoChem™ HT-2000 (or HT-1000). Physicians should decide which drugs to use with ThermoChem™ HT-2000 (or HT-1000) based upon their good judgment and understanding of the strengths and limitations of the data, and should consider the literature to guide their use of HIPEC with ThermoChem™ HT-2000 (or HT-1000).

Home
Request Info
News
Privacy statement
Disclaimer

Home
Our Story
Products
Distributors
Training & Support
Request Info
Job Openings
News
Contact Us

Our Certifications

Follow Us